| View | NM_000156.6(GAMT):c.*11C>T | Benign | guanidinoacetate methyltransferase deficiency | 2024-05-01 | 1.3 | ClinGen Cerebral Creatine Deficiency Syndromes Expert Panel Specifications to the ACMG/AMP
Variant Interpretation Guidelines for GAMT Version 1 | GAMT |
| View | NM_000156.6(GAMT):c.*11C>T | Benign | guanidinoacetate methyltransferase deficiency | 2024-05-01 | 1.2 | ClinGen Cerebral Creatine Deficiency Syndromes Expert Panel Specifications to the ACMG/AMP
Variant Interpretation Guidelines for GAMT Version 1 | GAMT |
| View | NM_000156.6(GAMT):c.*11C>T | Benign | guanidinoacetate methyltransferase deficiency | 2024-05-01 | 1.1 | ClinGen Cerebral Creatine Deficiency Syndromes Expert Panel Specifications to the ACMG/AMP
Variant Interpretation Guidelines for GAMT Version 1 | GAMT |
| View | NM_000156.6(GAMT):c.*11C>T | Benign | guanidinoacetate methyltransferase deficiency | 2022-10-07 | 1.0 | ClinGen Cerebral Creatine Deficiency Syndromes Expert Panel Specifications to the ACMG/AMP
Variant Interpretation Guidelines for GAMT Version 1 | GAMT |